Prevalence of Nonradiographic Sacroiliitis Low Among Patients With Psoriatic Arthritis
Researchers assessed the prevalence of nonradiographic sacroiliitis in patients with psoriatic arthritis, using pelvic radiographs and MRI of sacroiliac joints.
Spondyloarthritis
Behçet Disease Associated With Increased Risk for Psoriasis and Psoriatic Arthritis
Researchers assessed the association between Behçet disease and psoriasis and psoriatic arthritis, using data from the National Health Insurance Service of Korea.
Assessing Health-Related Quality of Life in Early Psoriatic Arthritis vs Early Rheumatoid Arthritis
Researchers evaluated the health-related quality of life in patients with early psoriatic arthritis compared with those with early rheumatoid arthritis and a general population.
Widespread, Extra-Articular Pain Common in Patients With Psoriatic Arthritis
Researchers evaluated pain areas in patients with psoriatic arthritis compared with those with fibromyalgia.
Fatigue Assessment Included in Golimumab Labeling
The prescribing information for the product has been updated to include this health related outcome.
Can Stepdown MTX Therapy Lead to TNFi Discontinuation in Patients With SpA in Clinical Remission?
Researchers assessed whether the addition of methotrexate would enable discontinuation of golimumab in patients with peripheral spondyloarthritis in sustained clinical remission.
Long-Term Changes in Sexual Quality of Life in Patients With Axial Spondyloarthritis
Study authors assessed perception of sexual quality of life in men and women with axial spondyloarthritis, after a 5-year follow-up.
Independent Factors Affect Prognosis of Cervical Spine Fractures in Patients With Ankylosing Spondylitis
Researchers assessed the prognostic factors of postoperative outcomes for cervical spine fractures in patients with ankylosing spondylitis.
Tenderness May Not Be Sign of Inflammation in Established RA, PsA, and OA
Researchers assessed whether clinical tenderness can be considered a sign of inflammatory joint activity in patients with rheumatoid arthritis, osteoarthritis, and psoriatic arthritis.
Axial Disease Improvements Demonstrated With Secukinumab for Psoriatic Arthritis
MAXIMISE trial results demonstrate the safety and efficacy of secukinumab 300 mg and 150 mg treatment for axial disease in people with psoriatic arthritis.
-
Loading...
-
Loading...
Next post in Spondyloarthritis
